SERA
Sera Prognostics, Inc.
Price Chart
Latest Quote
$1.75
-0.14 (-7.41%)
Current Price
| Previous Close | $1.89 |
| Open | $1.88 |
| Day High | $1.92 |
| Day Low | $1.75 |
| Volume | 72,251 |
Stock Information
| Shares Outstanding | 38.19M |
| Total Debt | $2.50M |
| Cash Equivalents | $47.40M |
| Revenue | $57K |
| Net Income | $-32.14M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $68.53M |
| EPS (TTM) | $-0.64 |
| Exchange | NGM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $23.63M |
| Sales | $57K |
| Income | $-32.14M |
| Book/sh | $1.94 |
| Cash/sh | $1.24 |
| Employees | 71 |
Financial Ratios
| Quick Ratio | 2.02 |
| Current Ratio | 2.12 |
| Debt/Eq | 3.71 |
Returns & Margins
| ROA | -21.62% |
| ROE | -39.58% |
| Gross Margin | -191.23% |
| Operating Margin | -66857.14% |
Ownership
| Insider Ownership | 11.52% |
| Institutional Ownership | 63.14% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -3.03 |
| P/S | 1202.24 |
| P/B | 0.90 |
Analyst Data
| Recommendation | none |
| Target Price | $5.50 |
Technical Indicators
| SMA20 | $2.03 |
| SMA50 | $1.99 |
| SMA200 | $2.69 |
| RSI | 31.86 |
| ATR | 0.1878 |
| Shares Float | 27.48M |
| Short Float | 0.96% |
| Short Ratio | 3.83 |
| Volatility | 0.94 |
| Rel Volume | 1.14 |
Performance History
| Week | -9.33% |
| Month | +0.57% |
| Quarter | -2.23% |
| 6 Months | -50.84% |
| YTD | -41.67% |
| Year | -4.89% |
| 3 Years | -48.98% |
| 10 Years | -85.29% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $1.75 | 87,500 |
| 2026-06-17 | $1.89 | 25,200 |
| 2026-06-16 | $1.86 | 49,200 |
| 2026-06-15 | $1.84 | 45,500 |
| 2026-06-12 | $1.87 | 50,000 |
| 2026-06-11 | $1.93 | 51,400 |
| 2026-06-10 | $2.00 | 99,300 |
| 2026-06-09 | $2.13 | 57,700 |
| 2026-06-08 | $2.10 | 36,400 |
| 2026-06-05 | $2.29 | 33,600 |
| 2026-06-04 | $2.24 | 100,900 |
| 2026-06-03 | $2.05 | 20,300 |
| 2026-06-02 | $2.04 | 36,700 |
| 2026-06-01 | $2.19 | 29,400 |
| 2026-05-29 | $2.16 | 35,100 |
| 2026-05-28 | $2.14 | 42,000 |
| 2026-05-27 | $2.19 | 38,200 |
| 2026-05-26 | $2.15 | 133,800 |
| 2026-05-22 | $2.07 | 532,000 |
| 2026-05-21 | $1.80 | 25,400 |
| 2026-05-20 | $1.76 | 56,400 |
| 2026-05-19 | $1.74 | 16,900 |
About Sera Prognostics, Inc.
Sera Prognostics, Inc., a women's health company, discovers, develops, and commercializes blood-based biomarker tests, and predictive analytic products and services in the United States. The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 through 20 of gestation. It is also involved in the development of a pipeline of novel blood-based biomarker tests and predictive analytic products and services for pregnancy related conditions, such as time-to-birth, predictive analytics product, pregnancy risk prediction panel, preeclampsia, and fetal growth restriction. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.
đ° Latest News
All You Need to Know About Sera Prognostics (SERA) Rating Upgrade to Buy
Zacks âĸ 2026-06-19T16:00:04Z
SunCar Technology Group And 2 Other Promising Penny Stocks For Savvy Investors
Simply Wall St. âĸ 2026-05-28T12:05:05Z
Sera Prognostics (SERA) Loses 27% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Zacks âĸ 2026-05-14T13:35:02Z
Will Sera Prognostics (NASDAQ:SERA) Spend Its Cash Wisely?
Simply Wall St. âĸ 2026-05-08T10:39:25Z
Sera Prognostics, Inc. Q1 2026 Earnings Call Summary
Moby âĸ 2026-05-07T12:30:00Z
Sera Prognostics Q1 Earnings Call Highlights
MarketBeat âĸ 2026-05-07T05:12:06Z
Sera Prognostics, Inc. (SERA) Reports Q1 Loss, Misses Revenue Estimates
Zacks âĸ 2026-05-06T22:30:06Z
Sera Prognostics (SERA) Upgraded to Buy: What Does It Mean for the Stock?
Zacks âĸ 2026-03-31T16:00:04Z
5 Top-Ranked Stocks With Rising P/E That Investors Can Bet On
Zacks âĸ 2026-03-31T12:30:00Z
Sera Prognostics, Inc. Q4 2025 Earnings Call Summary
Moby âĸ 2026-03-19T12:30:00Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $164,000 | $82,000 | $210,000 | $193,000 |
| Cost Of Revenue | $164,000 | $82,000 | $210,000 | $193,000 |
| Total Revenue | $81,000 | $77,000 | $306,000 | $268,000 |
| Operating Revenue | $81,000 | $77,000 | $306,000 | $268,000 |
| Expenses | ||||
| Interest Expense | $9,000 | $28,000 | $55,000 | $61,000 |
| Total Expenses | $36,585,000 | $36,712,000 | $40,127,000 | $45,920,000 |
| Other Income Expense | $332,000 | $1,018,000 | $1,994,000 | $1,071,000 |
| Net Non Operating Interest Income Expense | $4,244,000 | $2,719,000 | $1,585,000 | $395,000 |
| Interest Expense Non Operating | $9,000 | $28,000 | $55,000 | $61,000 |
| Operating Expense | $36,421,000 | $36,630,000 | $39,917,000 | $45,727,000 |
| Selling And Marketing Expense | $6,548,000 | $5,771,000 | $8,349,000 | $14,699,000 |
| General And Administrative Expense | $16,702,000 | $16,129,000 | $16,343,000 | $16,784,000 |
| Other Non Operating Income Expenses | - | - | - | - |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-31,928,000 | $-32,898,000 | $-36,242,000 | $-44,186,000 |
| Net Interest Income | $4,244,000 | $2,719,000 | $1,585,000 | $395,000 |
| Interest Income | $4,253,000 | $2,747,000 | $1,640,000 | $456,000 |
| Normalized Income | $-32,260,000 | $-33,916,000 | $-38,236,000 | $-45,257,000 |
| Net Income From Continuing And Discontinued Operation | $-31,928,000 | $-32,898,000 | $-36,242,000 | $-44,186,000 |
| Total Operating Income As Reported | $-36,504,000 | $-36,635,000 | $-39,821,000 | $-45,652,000 |
| Net Income Common Stockholders | $-31,928,000 | $-32,898,000 | $-36,242,000 | $-44,186,000 |
| Net Income | $-31,928,000 | $-32,898,000 | $-36,242,000 | $-44,186,000 |
| Net Income Including Noncontrolling Interests | $-31,928,000 | $-32,898,000 | $-36,242,000 | $-44,186,000 |
| Net Income Continuous Operations | $-31,928,000 | $-32,898,000 | $-36,242,000 | $-44,186,000 |
| Pretax Income | $-31,928,000 | $-32,898,000 | $-36,242,000 | $-44,186,000 |
| Interest Income Non Operating | $4,253,000 | $2,747,000 | $1,640,000 | $456,000 |
| Operating Income | $-36,504,000 | $-36,635,000 | $-39,821,000 | $-45,652,000 |
| Gross Profit | $-83,000 | $-5,000 | $96,000 | $75,000 |
| Special Income Charges | - | - | - | $0 |
| Per Share | ||||
| Diluted EPS | $-0.67 | $-0.99 | $-1.16 | $-1.43 |
| Basic EPS | $-0.67 | $-0.99 | $-1.16 | $-1.43 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-31,311,000 | $-33,055,000 | $-37,281,000 | $-44,440,000 |
| Total Unusual Items | $332,000 | $1,018,000 | $1,994,000 | $1,071,000 |
| Total Unusual Items Excluding Goodwill | $332,000 | $1,018,000 | $1,994,000 | $1,071,000 |
| Reconciled Depreciation | $940,000 | $833,000 | $900,000 | $756,000 |
| EBITDA (Bullshit earnings) | $-30,979,000 | $-32,037,000 | $-35,287,000 | $-43,369,000 |
| EBIT | $-31,919,000 | $-32,870,000 | $-36,187,000 | $-44,125,000 |
| Diluted Average Shares | $47,662,078 | $33,156,936 | $31,200,652 | $30,943,426 |
| Basic Average Shares | $47,662,078 | $33,156,936 | $31,200,652 | $30,943,426 |
| Diluted NI Availto Com Stockholders | $-31,928,000 | $-32,898,000 | $-36,242,000 | $-44,186,000 |
| Gain On Sale Of Security | $332,000 | $1,018,000 | $1,994,000 | $1,071,000 |
| Research And Development | $13,171,000 | $14,730,000 | $15,225,000 | $14,244,000 |
| Selling General And Administration | $23,250,000 | $21,900,000 | $24,692,000 | $31,483,000 |
| Other Gand A | $16,702,000 | $16,129,000 | $16,343,000 | $16,784,000 |
| Other Special Charges | - | - | - | - |
Fetched: 2026-06-19
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $74,498,000 | $46,777,000 | $70,158,000 | $98,943,000 |
| Total Assets | $101,933,000 | $72,575,000 | $95,441,000 | $116,329,000 |
| Total Non Current Assets | $61,163,000 | $24,975,000 | $34,097,000 | $26,204,000 |
| Other Non Current Assets | $2,525,000 | $737,000 | $1,257,000 | $1,816,000 |
| Investmentin Financial Assets | $56,579,000 | $21,973,000 | $30,841,000 | $21,329,000 |
| Goodwill And Other Intangible Assets | $910,000 | $1,026,000 | $0 | - |
| Other Intangible Assets | $910,000 | $1,026,000 | - | - |
| Current Assets | $40,770,000 | $47,600,000 | $61,344,000 | $90,125,000 |
| Other Current Assets | $1,557,000 | $1,330,000 | $795,000 | $1,308,000 |
| Receivables | $12,000 | $34,000 | $11,470,000 | $6,113,000 |
| Accounts Receivable | $12,000 | $34,000 | $160,000 | $113,000 |
| Cash Cash Equivalents And Short Term Investments | $39,201,000 | $46,236,000 | $49,079,000 | $82,704,000 |
| Cash And Cash Equivalents | $3,944,000 | $4,043,000 | $3,880,000 | $29,878,000 |
| Cash Equivalents | $2,128,000 | $2,060,000 | $1,272,000 | $28,965,000 |
| Cash Financial | $1,816,000 | $1,983,000 | $2,608,000 | $913,000 |
| Other Receivables | - | $19,000 | $11,310,000 | $6,000,000 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Total Debt | $2,339,000 | $840,000 | $1,858,000 | $2,831,000 |
| Long Term Debt And Capital Lease Obligation | $2,337,000 | $2,000 | $840,000 | $1,848,000 |
| Current Debt And Capital Lease Obligation | $2,000 | $838,000 | $1,018,000 | $983,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $26,525,000 | $24,772,000 | $25,283,000 | $17,386,000 |
| Total Non Current Liabilities Net Minority Interest | $2,337,000 | $2,000 | $840,000 | $1,848,000 |
| Current Liabilities | $24,188,000 | $24,770,000 | $24,443,000 | $15,538,000 |
| Other Current Liabilities | $445,000 | $296,000 | $926,000 | $637,000 |
| Current Deferred Liabilities | $20,315,000 | $20,223,000 | $20,235,000 | $9,082,000 |
| Payables And Accrued Expenses | $862,000 | $1,969,000 | $1,120,000 | $2,546,000 |
| Payables | $862,000 | $1,969,000 | $1,046,000 | $1,548,000 |
| Accounts Payable | $862,000 | $1,969,000 | $1,046,000 | $1,548,000 |
| Derivative Product Liabilities | - | - | - | - |
| Non Current Deferred Liabilities | - | - | - | - |
| Interest Payable | - | - | - | - |
| Equity | ||||
| Common Stock Equity | $75,408,000 | $47,803,000 | $70,158,000 | $98,943,000 |
| Total Equity Gross Minority Interest | $75,408,000 | $47,803,000 | $70,158,000 | $98,943,000 |
| Stockholders Equity | $75,408,000 | $47,803,000 | $70,158,000 | $98,943,000 |
| Gains Losses Not Affecting Retained Earnings | $262,000 | $60,000 | $-15,000 | $-981,000 |
| Other Equity Adjustments | $262,000 | $60,000 | $-15,000 | $-981,000 |
| Retained Earnings | $-311,722,000 | $-279,794,000 | $-246,896,000 | $-210,654,000 |
| Preferred Securities Outside Stock Equity | - | - | - | - |
| Other | ||||
| Ordinary Shares Number | $38,944,523 | $34,174,668 | $31,704,272 | $31,017,946 |
| Share Issued | $38,944,523 | $34,174,668 | $31,704,272 | $31,017,946 |
| Tangible Book Value | $74,498,000 | $46,777,000 | $70,158,000 | $98,943,000 |
| Invested Capital | $75,408,000 | $47,803,000 | $70,158,000 | $98,943,000 |
| Working Capital | $16,582,000 | $22,830,000 | $36,901,000 | $74,587,000 |
| Capital Lease Obligations | $2,339,000 | $840,000 | $1,858,000 | $2,831,000 |
| Total Capitalization | $75,408,000 | $47,803,000 | $70,158,000 | $98,943,000 |
| Additional Paid In Capital | $386,864,000 | $327,534,000 | $317,066,000 | $310,575,000 |
| Capital Stock | $4,000 | $3,000 | $3,000 | $3,000 |
| Common Stock | $4,000 | $3,000 | $3,000 | $3,000 |
| Long Term Capital Lease Obligation | $2,337,000 | $2,000 | $840,000 | $1,848,000 |
| Current Deferred Revenue | $20,315,000 | $20,223,000 | $20,235,000 | $9,082,000 |
| Current Capital Lease Obligation | $2,000 | $838,000 | $1,018,000 | $983,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $2,564,000 | $1,444,000 | $1,144,000 | $2,290,000 |
| Investments And Advances | $56,579,000 | $21,973,000 | $30,841,000 | $21,329,000 |
| Available For Sale Securities | $56,579,000 | $21,973,000 | $30,841,000 | $21,329,000 |
| Net PPE | $1,149,000 | $1,239,000 | $1,999,000 | $3,059,000 |
| Accumulated Depreciation | $-8,519,000 | $-7,756,000 | $-7,022,000 | $-6,256,000 |
| Gross PPE | $9,668,000 | $8,995,000 | $9,021,000 | $9,315,000 |
| Leases | $772,000 | $772,000 | $772,000 | $710,000 |
| Other Properties | $5,734,000 | $5,663,000 | $5,734,000 | $5,914,000 |
| Machinery Furniture Equipment | $3,162,000 | $2,560,000 | $2,515,000 | $2,691,000 |
| Properties | $0 | $0 | $0 | $0 |
| Other Short Term Investments | $35,257,000 | $42,193,000 | $45,199,000 | $52,826,000 |
| Current Accrued Expenses | - | $0 | $74,000 | $998,000 |
Fetched: 2026-06-19
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-26,349,000 | $-15,290,000 | $-27,316,000 | $-35,401,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-25,623,000 | $-14,189,000 | $-27,188,000 | $-34,610,000 |
| Cash Flow From Continuing Operating Activities | $-25,623,000 | $-14,189,000 | $-27,188,000 | $-34,610,000 |
| Operating Gains Losses | $314,000 | $-910,000 | $-1,182,000 | $-239,000 |
| Investing Activities | ||||
| Capital Expenditure | $-726,000 | $-1,101,000 | $-128,000 | $-791,000 |
| Investing Cash Flow | $-28,502,000 | $11,743,000 | $438,000 | $5,551,000 |
| Cash Flow From Continuing Investing Activities | $-28,502,000 | $11,743,000 | $438,000 | $5,551,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $53,610,000 | $0 | - | $0 |
| Financing Cash Flow | $54,026,000 | $2,609,000 | $752,000 | $5,000 |
| Cash Flow From Continuing Financing Activities | $54,026,000 | $2,609,000 | $752,000 | $5,000 |
| Net Common Stock Issuance | $53,610,000 | $0 | - | $0 |
| Common Stock Issuance | $53,610,000 | $0 | - | $0 |
| Net Preferred Stock Issuance | - | - | - | $0 |
| Preferred Stock Issuance | - | - | - | $0 |
| Other | ||||
| Repayment Of Debt | $-194,000 | $-440,000 | $-466,000 | $-303,000 |
| Interest Paid Supplemental Data | $9,000 | $28,000 | $55,000 | $48,000 |
| End Cash Position | $3,944,000 | $4,043,000 | $3,880,000 | $29,878,000 |
| Beginning Cash Position | $4,043,000 | $3,880,000 | $29,878,000 | $58,932,000 |
| Changes In Cash | $-99,000 | $163,000 | $-25,998,000 | $-29,054,000 |
| Proceeds From Stock Option Exercised | $610,000 | $3,049,000 | $1,218,000 | $308,000 |
| Net Issuance Payments Of Debt | $-194,000 | $-440,000 | $-466,000 | $-303,000 |
| Net Long Term Debt Issuance | $-194,000 | $-440,000 | $-466,000 | $-303,000 |
| Long Term Debt Payments | $-194,000 | $-440,000 | $-466,000 | $-303,000 |
| Net Investment Purchase And Sale | $-27,776,000 | $12,844,000 | $255,000 | $6,326,000 |
| Sale Of Investment | $59,836,000 | $48,675,000 | $54,398,000 | $54,399,000 |
| Purchase Of Investment | $-87,612,000 | $-35,831,000 | $-54,143,000 | $-48,073,000 |
| Net Intangibles Purchase And Sale | $0 | $-1,045,000 | $0 | - |
| Purchase Of Intangibles | $0 | $-1,045,000 | $0 | - |
| Net PPE Purchase And Sale | $-726,000 | $-56,000 | $183,000 | $-775,000 |
| Purchase Of PPE | $-726,000 | $-56,000 | $-128,000 | $-791,000 |
| Change In Working Capital | $-546,000 | $11,275,000 | $3,519,000 | $3,552,000 |
| Change In Other Working Capital | $92,000 | $-12,000 | $11,154,000 | $5,966,000 |
| Change In Payables And Accrued Expense | $-327,000 | $-120,000 | $-2,743,000 | $-162,000 |
| Change In Accrued Expense | $682,000 | $-575,000 | $-2,301,000 | $-514,000 |
| Change In Payable | $-1,009,000 | $455,000 | $-442,000 | $352,000 |
| Change In Account Payable | $-1,009,000 | $455,000 | $-442,000 | $352,000 |
| Change In Prepaid Assets | $-352,000 | $-10,000 | $465,000 | $718,000 |
| Change In Receivables | $41,000 | $11,417,000 | $-5,357,000 | $-2,970,000 |
| Changes In Account Receivables | $22,000 | $126,000 | $-47,000 | $-86,000 |
| Other Non Cash Items | $487,000 | $498,000 | $544,000 | $452,000 |
| Stock Based Compensation | $5,110,000 | $7,013,000 | $5,273,000 | $5,055,000 |
| Depreciation Amortization Depletion | $940,000 | $833,000 | $900,000 | $756,000 |
| Depreciation And Amortization | $940,000 | $833,000 | $900,000 | $756,000 |
| Gain Loss On Investment Securities | $314,000 | $-910,000 | $-1,182,000 | $-239,000 |
| Net Income From Continuing Operations | $-31,928,000 | $-32,898,000 | $-36,242,000 | $-44,186,000 |
| Sale Of PPE | - | $0 | $311,000 | $16,000 |
| Issuance Of Debt | - | - | - | - |
| Long Term Debt Issuance | - | - | - | - |
Fetched: 2026-06-19